Assessing Relapse in Multiple Sclerosis Questionnaire: Results of a Pilot Study

Table 2

Characteristics of current relapse.

	Patients completing Part 1 of ARMS questionnaire (𝑁 = 103)
Time since symptoms began, 𝑛 (%)
≤3 days	8 (8)
4–7 days	26 (25)
8–15 days	30 (29)
≥16 days	39 (38)
Effect of symptoms on ADL, 𝑛 (%)
A little	9 (9)
Somewhat	35 (34)
Very much	48 (47)
Severely	11 (11)
Mean (SD) ADL score	6.62 (2.1)

ARMS: Assessing Relapse in Multiple Sclerosis; ADL: activities of daily living; SD: standard deviation.